The stock of Encompass Health Corporation (NYSE:EHC) last traded at $69.32, up 5.09% from the previous session.
Data from the available sources indicates that Encompass Health Corporation (NYSE:EHC) is covered by 12 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $84.00 and a low of $61.00, we find $76.00. Given the previous closing price of $65.96, this indicates a potential upside of 15.22 percent. EHC stock price is now 6.77% away from the 50-day moving average and 16.15% away from the 200-day moving average. The market capitalization of the company currently stands at $6.86B.
In total, 1 analysts have assigned it a hold rating, and 11 have given it a buy rating. Brokers who have rated the stock have averaged $76.09 as their price target over the next twelve months.
With the price target of $57, Barclays recently initiated with Equal Weight rating for Encompass Health Corporation (NYSE: EHC).
In other news, COLTHARP DOUGLAS E, EVP & Chief Financial Officer sold 17,895 shares of the company’s stock on Feb 10. The stock was sold for $1,087,658 at an average price of $60.78. Upon completion of the transaction, the EVP & Chief Financial Officer now directly owns 53,097 shares in the company, valued at $3.68 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 31, Director CARMICHAEL GREG D bought 1,830 shares of the business’s stock. A total of $100,046 was incurred on buying the stock at an average price of $54.67. This leaves the insider owning 10,546 shares of the company worth $0.73 million. Insiders disposed of 80,970 shares of company stock worth roughly $5.61 million over the past 1 year. A total of 1.00% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in EHC stock. A new stake in Encompass Health Corporation shares was purchased by QUBE RESEARCH & TECHNOLOGIES LTD during the first quarter worth $16,806,000. GREAT LAKES ADVISORS, LLC invested $15,284,000 in shares of EHC during the first quarter. In the first quarter, MARSHALL WACE, LLP acquired a new stake in Encompass Health Corporation valued at approximately $14,318,000. TWIN TREE MANAGEMENT, LP acquired a new stake in EHC for approximately $9,070,000. AMUNDI purchased a new stake in EHC valued at around $8,337,000 in the second quarter.
With an opening price of $68.44 on Wednesday morning, Encompass Health Corporation (NYSE: EHC) set off the trading day. During the past 12 months, Encompass Health Corporation has had a low of $45.11 and a high of $68.99. As of last week, the company has a debt-to-equity ratio of 1.99, a current ratio of 1.30, and a quick ratio of 1.30. According to the stock market information, the enterprise value for the company is $9.50B, which is based on a 24.72 price-to-earnings ratio, a 2.40 price-to-earnings-growth ratio, and a beta of 1.06. The fifty day moving average price for EHC is $65.08 and a two-hundred day moving average price translates $59.79 for the stock.
According to the Medical Care Facilities Company, earnings per share came in at $0.95, beating analysts’ expectations of $0.74 by 0.21. This compares to $0.23 EPS in the same period last year. The company reported revenue of $1.16 billion for the quarter, compared to $1.06 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 9.54 percent. For the current quarter, analysts expect EHC to generate $1.19B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 10/16/2023. Investors who held shares on 10/02/2023 were paid a $0.15 dividend. On an annualized basis, this represents a $0.60 dividend and a 0.87% percent yield. There was an ex-dividend date of 09/29/2023 for this dividend. In terms of dividend payout ratio, EHC is presently at 33.72%.
